One reason COVID-19-related mortality is decreasing is a more aggressive management of the hyperinflammatory phase of advanced COVID-19. But what’s the scientific evidence for and clinical experience of these treatments?
An article published in the Cleveland Clinic Journal of Medicine outlines current guidelines in prostate cancer screening from the lens of a urologist practicing in the UK.
The decision to screen for prostate cancer is a complicated one. A Cleveland Clinic medical oncologist discusses overdiagnosis and recommends a new path forward.
The physiologic roles of androgens and best-practice recommendations for androgen therapy in women.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A team of Cleveland Clinic experts considers the clinical implications of at-home COVID-19 tests in a recent article.
What to look for and how to manage symptoms of COVID-19 in the pediatric population.
The relationship between nephrogenic systemic fibrosis and the use of gadolinium as contrast during MRI remained obscure for a long time. Cleveland Clinic nephrologists discuss the current literature, risks and updated guidelines.
Studying the ophthalmic effects of COVID-19 infection could potentially lead to earlier diagnosis and aid in disease management.
New data question the efficacy of IL-6 inhibitors for the treatment of COVID-19. This article explores what we know about the safety and efficacy of targeting IL-6.
Cleveland Clinic pulmonologists discuss the limitations of current modalities designed to treat emphysema and review the rationale, evidence and applications of valve therapy.